| Bladder Urothelial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 47show all (up to 200) |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 21 trials (14 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 20 trials (14 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |